Diagnosis and treatment of hepatic, bilio-pancreatic, and peritoneal tuberculosis
- By Aboudou Raïmi Kpossou,
- Ablo Prudence Wachinou,
- Olivier Nouel,
- Jean-François Cadranel
- and Jean Séhonou
Pages 718 to 725
Cite this article
- KPOSSOU, Aboudou Raïmi,
- WACHINOU, Ablo Prudence,
- NOUEL, Olivier,
- CADRANEL, Jean-François
- and SÉHONOU, Jean,
- Kpossou, Aboudou Raïmi.,
- et al.
- Kpossou, A.-R.,
- Wachinou, A.-P.,
- Nouel, O.,
- Cadranel, J.-F.
- and Séhonou, J.
https://doi.org/10.1684/hpg.2022.2401
Cite this article
- Kpossou, A.-R.,
- Wachinou, A.-P.,
- Nouel, O.,
- Cadranel, J.-F.
- and Séhonou, J.
- Kpossou, Aboudou Raïmi.,
- et al.
- KPOSSOU, Aboudou Raïmi,
- WACHINOU, Ablo Prudence,
- NOUEL, Olivier,
- CADRANEL, Jean-François
- and SÉHONOU, Jean,
https://doi.org/10.1684/hpg.2022.2401
Abdominal tuberculosis, in addition to the digestive tract, may involve the peritoneum or solid viscera such as the liver and pancreas. Hepatic and bilio-pancreatic localizations are rarely symptomatic and difficult to diagnose. Peritoneal involvement often poses the problem of etiological investigation of protein-rich ascites. The diagnosis is based on bacteriological and histological analysis of ascites fluid and tissue samples. The differential diagnosis is essentially with malignant tumors and granulomatosis. Treatment is medical and involves anti-tuberculosis drugs.